Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Jersey City › NPI 1871859306
Hospital

Hudson Hospital Opco LLC

Hudson Hospital Opco LLC was paid $52.54M by Medicaid between Jan 2018 and Dec 2024, across 268 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.

33Billing provider infoHUDSON HOSPITAL OPCO LLC
JERSEY CITY, NJ 07306
33aNPI1871859306assigned 04/10/2012
33bProvider typeGeneral Acute Care Hospital
28Total paid$52.54M
24GClaims1,041,366
24DCodes billed268
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#31 of 93
Median peer was paid$30.60M
This provider vs. median1.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018165,736$11.29M
2019158,802$9.80M
2020102,637$5.99M
2021130,506$7.63M
2022183,511$7.84M
2023193,014$6.16M
2024incomplete107,160$3.82M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 37,669 34,230 $12.06M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 18% 36,904 33,175 $9.66M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 16% 27,321 24,198 $8.44M
G0378 Hospital observation service, per hour 8.2% 8,185 5,070 $4.29M
90832 Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient 6.1% 26,441 14,429 $3.20M
OP250 3.0% 75,877 54,939 $1.59M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.7% 2,898 2,579 $1.42M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 2.6% 17,989 17,231 $1.35M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.8% 5,703 5,105 $960K
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.5% 2,101 1,928 $767K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 696 657 $414K
80053 Comprehensive metabolic panel <1% 45,444 34,648 $376K
256 more codes
77067 Screening mammography, bilateral, including computer-aided detection <1% 5,612 $349K
71046 Radiologic examination, chest; 2 views <1% 12,074 $328K
70450 Computed tomography, head or brain; without contrast material <1% 6,469 $254K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 4,189 $224K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 12,131 $209K
71045 Radiologic examination, chest; single view <1% 11,507 $196K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 47,037 $194K
82948 <1% 24,330 $194K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 9,415 $190K
90791 Psychiatric diagnostic evaluation <1% 1,803 $183K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 2,349 $175K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 18,122 $175K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 370 $173K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 4,710 $167K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 150 $155K
70486 <1% 1,267 $155K
OP710 <1% 12,837 $149K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 13,841 $120K
OP370 <1% 12,720 $120K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 6,622 $120K
76830 Ultrasound, transvaginal <1% 1,683 $117K
81025 <1% 9,093 $110K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 765 $101K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,428 $101K
90792 Psychiatric diagnostic evaluation with medical services <1% 916 $94K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 16,386 $93K
OP251 <1% 13,001 $92K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,772 $89K
83992 <1% 7,227 $88K
OP272 <1% 13,319 $87K
96361 Intravenous infusion, hydration; each additional hour <1% 10,014 $86K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,666 $86K
J7030 Infusion, normal saline solution , 1000 cc <1% 11,916 $85K
73630 <1% 2,562 $70K
93017 <1% 1,126 $68K
90837 Psychotherapy session, about an hour <1% 3,133 $62K
80361 <1% 7,204 $61K
30140 <1% 30 $59K
80345 <1% 7,205 $58K
80349 <1% 7,202 $58K
80353 <1% 7,203 $58K
80324 <1% 7,229 $58K
80346 <1% 7,200 $58K
36415 Collection of venous blood by venipuncture <1% 20,266 $57K
80358 <1% 7,204 $54K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 4,691 $53K
73610 <1% 2,199 $53K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 376 $52K
81001 <1% 32,631 $50K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,611 $50K
73562 <1% 2,351 $49K
77080 <1% 991 $49K
84443 Thyroid stimulating hormone (TSH) <1% 4,175 $46K
72100 <1% 1,924 $45K
99213 Doctor's office visit, returning patient (routine) <1% 2,906 $45K
96375 Therapeutic injection; each additional sequential IV push <1% 11,886 $45K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 3,397 $45K
86850 <1% 4,224 $45K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 129 $43K
73030 <1% 1,744 $41K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 3,627 $41K
88342 <1% 2,656 $39K
84484 <1% 12,491 $39K
90834 Psychotherapy session, about 45 minutes <1% 1,444 $38K
80048 Basic metabolic panel (calcium, ionized) <1% 5,653 $36K
80061 Lipid panel <1% 3,999 $34K
76770 <1% 487 $33K
85610 <1% 13,730 $32K
70551 Magnetic resonance imaging, brain; without contrast material <1% 166 $31K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 98 $29K
83880 <1% 4,403 $29K
30802 <1% 30 $28K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 574 $28K
84703 <1% 10,341 $27K
85730 <1% 12,915 $27K
83735 <1% 10,357 $27K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,141 $26K
90847 Family psychotherapy with the patient present, 50 minutes <1% 314 $25K
73130 <1% 1,046 $24K
96376 <1% 5,111 $23K
93970 <1% 365 $23K
76641 <1% 382 $22K
84100 <1% 8,603 $21K
74022 <1% 1,522 $21K
88304 <1% 1,911 $21K
71250 <1% 324 $21K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 867 $21K
86900 <1% 4,301 $20K
71275 Computed tomographic angiography, chest, with contrast material <1% 485 $20K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 4,178 $20K
0012A <1% 776 $20K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,385 $20K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,293 $19K
84702 <1% 3,075 $18K
0011A <1% 810 $18K
76642 <1% 445 $18K
J2704 Injection, propofol, 10 mg <1% 9,308 $18K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 5,412 $17K
OP270 <1% 10,738 $17K
73110 <1% 745 $17K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,222 $16K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,095 $16K
80320 <1% 2,795 $16K
83690 <1% 12,604 $15K
83036 Hemoglobin; glycosylated (A1C) <1% 4,341 $15K
74018 <1% 849 $15K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,384 $15K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 14 $15K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 4,366 $14K
64483 <1% 14 $14K
77065 Tomosynthesis, mammo <1% 292 $14K
87430 <1% 3,122 $13K
87040 <1% 3,664 $13K
82803 <1% 2,839 $13K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,360 $12K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 309 $12K
87070 <1% 4,027 $11K
OP258 <1% 4,017 $11K
77066 Tomosynthesis, mammo <1% 238 $11K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 3,052 $11K
85027 <1% 3,660 $11K
97802 <1% 109 $10K
84439 <1% 1,838 $9K
73140 <1% 399 $8K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 715 $8K
96367 <1% 683 $7K
J0690 Injection, cefazolin sodium, 500 mg <1% 2,393 $7K
76536 <1% 163 $6K
C1769 Guide wire <1% 149 $6K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,002 $6K
72125 Computed tomography, cervical spine; without contrast material <1% 193 $6K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 156 $6K
95811 <1% 13 $6K
J7120 Ringers lactate infusion, up to 1000 cc <1% 4,794 $6K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 26 $6K
82550 <1% 2,583 $6K
93976 <1% 39 $5K
97162 <1% 965 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,498 $4K
85378 <1% 2,457 $4K
88313 <1% 320 $4K
72040 <1% 256 $4K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 61 $4K
87807 <1% 1,055 $4K
73502 <1% 254 $3K
82607 <1% 757 $3K
90715 <1% 1,022 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,416 $3K
70480 <1% 98 $3K
82553 <1% 1,256 $3K
10060 <1% 51 $3K
97116 <1% 2,039 $3K
87181 <1% 1,849 $3K
73080 <1% 247 $3K
C9113 Injection, pantoprazole sodium, per vial <1% 4,004 $3K
94150 <1% 172 $3K
97161 <1% 376 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,352 $3K
93971 <1% 85 $3K
97803 <1% 59 $2K
84550 <1% 44 $2K
74240 <1% 36 $2K
12001 <1% 122 $2K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 260 $2K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 63 $2K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 150 $2K
0064A <1% 76 $2K
90853 Group psychotherapy (other than of a multiple-family group) <1% 62 $2K
71101 <1% 50 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,417 $2K
82728 <1% 247 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 12 $1K
29125 <1% 132 $1K
82570 <1% 715 $1K
86703 <1% 152 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,366 $1K
82746 <1% 401 $1K
J2785 Injection, regadenoson, 0.1 mg <1% 87 $934.86
97165 <1% 322 $929.57
93923 <1% 54 $922.93
99232 Hospital visit by a doctor, follow-up day <1% 74 $909.27
94760 <1% 58 $865.99
J1650 Injection, enoxaparin sodium, 10 mg <1% 3,775 $829.36
73660 <1% 12 $785.20
80074 <1% 77 $758.00
86140 <1% 415 $741.43
73590 <1% 44 $732.62
86592 <1% 77 $691.87
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,373 $665.84
0031A <1% 52 $664.45
88307 <1% 37 $631.48
70496 <1% 35 $631.18
70498 <1% 35 $631.18
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 468 $626.08
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 467 $626.08
85651 <1% 661 $573.28
82043 <1% 285 $566.57
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 1,095 $538.91
88312 <1% 131 $481.68
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 878 $448.63
J2060 Injection, lorazepam, 2 mg <1% 565 $421.98
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 16 $410.38
83550 <1% 170 $374.54
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,830 $348.91
74019 <1% 41 $327.64
76801 <1% 16 $300.03
83540 <1% 175 $268.50
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 671 $263.03
90714 <1% 25 $261.90
J1170 Injection, hydromorphone, up to 4 mg <1% 1,682 $232.92
84145 <1% 18 $208.52
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 171 $202.24
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,850 $187.55
83605 <1% 136 $185.84
83615 <1% 57 $182.13
82150 <1% 17 $168.32
90732 <1% 24 $149.34
82248 <1% 59 $137.49
86920 <1% 16 $123.87
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 497 $120.24
OP271 <1% 155 $110.41
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 899 $102.42
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg <1% 213 $98.04
86706 <1% 17 $96.25
82009 <1% 136 $90.52
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 593 $78.06
OP278 <1% 46 $70.93
76818 <1% 12 $63.48
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 72 $62.58
82378 <1% 16 $62.29
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 177 $55.40
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 242 $49.22
86038 <1% 13 $49.01
J1644 Injection, heparin sodium, per 1000 units <1% 922 $46.58
J7510 Prednisolone oral, per 5 mg <1% 465 $26.64
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 830 $21.00
94770 <1% 34 $17.67
90686 <1% 15 $17.52
84156 <1% 66 $14.32
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 82 $13.56
J2470 Injection, pantoprazole sodium, 40 mg <1% 107 $12.02
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 17 $9.12
G0008 Administration of influenza virus vaccine <1% 13 $8.00
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 149 $4.93
97535 Self-care/home management training, each 15 minutes <1% 29 $2.91
J0360 Injection, hydralazine hcl, up to 20 mg <1% 27 $2.76
V2632 Posterior chamber intraocular lens <1% 27 $2.00
J1630 Injection, haloperidol, up to 5 mg <1% 108 $2.00
J3480 Injection, potassium chloride, per 2 meq <1% 87 $1.00
J3475 Injection, magnesium sulfate, per 500 mg <1% 238 $1.00
OP255 <1% 17 $1.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 74 $0.00
97166 0% 39 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 65 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 34 $0.00
J3470 Injection, hyaluronidase, up to 150 units 0% 33 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRODRIGUEZ, FRANK (SYSTEM DIRECTOR OF MEDICAL STAFF)
Same official

Other billing entities under RODRIGUEZ, FRANK

Full network →
ProviderLocationPaid
Humc Opco LLCHoboken, NJ$57.36M
Ijkg Opco LLCBayonne, NJ$17.54M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.